Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes
Evidence-informed recommendations were developed by the Canadian Drug Expert Committee (CDEC) to address the following policy questions: 1. What is the optimal second-line therapy for patients with type 2 diabetes experiencing inadequate glycemic control with metformin monotherapy? 2. What is the op...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2013, July 2013
|
| Series: | CADTH optimal use report
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references